CSPC Pharmaceutical Group (SEHK:1093) Balance Sheet Analysis 2003-2025

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Metric	2024	2025
Total Cash And Short-Term Investments	HK$8.25B	HK$9.874B
Net Receivables	HK$9.938B	HK$10.635B
Inventory	HK$3.331B	HK$3.443B
Prepaid Expenses And Other Current Assets	HK$207.08M	HK$236.016M
Other Current Assets	HK$1.564B	HK$0.595B
Total Current Assets	HK$23.291B	HK$24.783B
Property, Plant And Equipment	HK$13.919B	HK$15.025B
Goodwill And Intangible Assets	HK$2.844B	HK$3.352B
Long-Term Investments	HK$6.733B	HK$7.997B
Deferred Tax Assets	HK$266.369M	HK$235.577M
Other Noncurrent Assets	HK$179.458M	HK$619.824M
Total Noncurrent Assets	HK$23.942B	HK$27.23B
Other Assets	-	-
Total Assets	HK$47.233B	HK$52.013B

Metric	2024	2025
Total Payables	HK$8.237B	HK$3.57B
Accrued Expenses	-	-
Short-Term Debt	HK$392.204M	HK$512.818M
Current Portion Of Lease Obligations	HK$58.991M	-
Income Taxes Payable	-	-
Current Deferred Revenue	-	HK$737.62M
Other Current Liabilities	HK$7.02B	HK$6.516B
Total Current Liabilities	HK$10.251B	HK$11.336B
Long-Term Debt	HK$-59.732M	HK$-201.258M
Capital Lease Obligations	HK$118.723M	HK$201.258M
Noncurrent Deferred Revenue	-	HK$948.007M
Noncurrent Deferred Tax Liabilities	HK$452.004M	HK$417.525M
Other Noncurrent Liabilities	-	HK$627.346M
Total Noncurrent Liabilities	HK$0.512B	HK$2.194B
Other Liabilities	-	-
Total Liabilities	HK$11.197B	HK$13.53B

Metric	2024	2025
Treasury Stock	HK$-651.341M	-
Preferred Stock	-	-
Common Stock	HK$11.74B	HK$12.32B
Retained Earnings	HK$24.843B	-
Additional Paid-In Capital	-	-
Accumulated Other Comprehensive Income	HK$-1.596B	-
Other Stockholders' Equity	-	HK$24.634B
Total Common Stockholders' Equity	HK$34.332B	HK$36.954B
Minority Interest	HK$1.704B	HK$1.528B
Total Equity	HK$36.036B	HK$38.482B
Total Liabilities And Equity	HK$47.233B	HK$52.013B

Metric	2024	2025
Total Investments	HK$8.207B	HK$11.089B
Total Debt	HK$507.33M	HK$714.076M
Net Debt	HK$-6.27B	HK$-6.069B

CSPC Pharmaceutical Group Balance Sheet

Balance Sheet Composition